124 related articles for article (PubMed ID: 11193877)
1. Cytosolic calcium handling in islets of normal Wistar and diabetic Goto Kakizaki rats in the presence of glucose and truncated glucagon-like peptide 1 (7-36) amide.
Marie JC; Bailbe D
Ann N Y Acad Sci; 2000; 921():464-8. PubMed ID: 11193877
[No Abstract] [Full Text] [Related]
2. GLP-1(7-36)amide-stimulated insulin secretion in rat islets is sodium-dependent.
Fridolf T; Ahrén B
Biochem Biophys Res Commun; 1991 Aug; 179(1):701-6. PubMed ID: 1883392
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.
Dachicourt N; Serradas P; Bailbé D; Kergoat M; Doaré L; Portha B
J Endocrinol; 1997 Nov; 155(2):369-76. PubMed ID: 9415071
[TBL] [Abstract][Full Text] [Related]
4. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.
Tourrel C; Bailbe D; Lacorne M; Meile MJ; Kergoat M; Portha B
Diabetes; 2002 May; 51(5):1443-52. PubMed ID: 11978641
[TBL] [Abstract][Full Text] [Related]
5. Induction of glucose competence in pancreatic beta cells by glucagon-like peptide-1(7-37).
Holz GH; Kuhtreiber WM; Habener JF
Trans Assoc Am Physicians; 1992; 105():260-7. PubMed ID: 1339238
[No Abstract] [Full Text] [Related]
6. Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.
Linn T; Schneider K; Göke B; Federlin K
Acta Diabetol; 1996 Mar; 33(1):19-24. PubMed ID: 8777280
[TBL] [Abstract][Full Text] [Related]
7. Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.
Jia X; Elliott R; Kwok YN; Pederson RA; McIntosh CH
Diabetes; 1995 May; 44(5):495-500. PubMed ID: 7729605
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP, a mediator of GLP-1, acts in concert with glucose and tolbutamide to increase cytosolic Ca2+ in pancreatic B-cells.
Yaekura K; Nakata M; Tanaka H; Yada T
Adv Exp Med Biol; 1997; 426():211-6. PubMed ID: 9544276
[No Abstract] [Full Text] [Related]
9. GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action.
Fridolf T; Ahrén B
Diabetes Res; 1991 Apr; 16(4):185-91. PubMed ID: 1802486
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.
Sreenan SK; Mittal AA; Dralyuk F; Pugh WL; Polonsky KS; Roe MW
Metabolism; 2000 Dec; 49(12):1579-87. PubMed ID: 11145120
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of incretin hormones on insulin release from pancreatic islets in the bile duct-ligated rats.
Niwa T; Nimura Y; Niki I
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E59-64. PubMed ID: 11120659
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
Gromada J; Dissing S; Bokvist K; Renström E; Frøkjaer-Jensen J; Wulff BS; Rorsman P
Diabetes; 1995 Jul; 44(7):767-74. PubMed ID: 7789644
[TBL] [Abstract][Full Text] [Related]
13. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
[TBL] [Abstract][Full Text] [Related]
14. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
Heller RS; Aponte GW
Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
[TBL] [Abstract][Full Text] [Related]
15. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
Hashiguchi S; Yada T; Arima T
J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
[TBL] [Abstract][Full Text] [Related]
16. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1(7-36)amide and cytoplasmic calcium in insulin producing cells.
Ahrén B; Simonsson E; Karlsson S
Acta Physiol Scand; 1996 Jul; 157(3):333-41. PubMed ID: 8830888
[No Abstract] [Full Text] [Related]
19. Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity.
Yada T; Itoh K; Nakata M
Endocrinology; 1993 Oct; 133(4):1685-92. PubMed ID: 8404610
[TBL] [Abstract][Full Text] [Related]
20. Glucagonlike peptide I (7-37) actions on endocrine pancreas.
Weir GC; Mojsov S; Hendrick GK; Habener JF
Diabetes; 1989 Mar; 38(3):338-42. PubMed ID: 2645190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
